$1 trillion investment shortage in senior living development expected by 2040
By
Kimberly Bonvissuto
Jun 27, 2024
A $275 billion investment gap in senior living development across the country by 2030 means there won’t be enough housing to meet the demand of older adults in the next five years, according to new data...
Omega Healthcare Investors reaches deal with estate of late Maplewood Senior Living CEO
By
Lois A. Bowers
Aug 05, 2024
Omega Healthcare Investors has reached a deal with the estate of Greg Smith, the late president and CEO of Maplewood Senior Living, to transition control of Maplewood to some members of the existing Maplewood...
Most traditional cardiovascular risk factors not linked to migraine
Jul 31, 2024
Current smoking, diabetes mellitus and higher fasting glucose level all were linked to lower prevalence of migraine in women.
Committee advances Older Americans Act reauthorization to full Senate
By
Kimberly Bonvissuto
Aug 02, 2024
The Older Americans Act cleared another hurdle on its path to reauthorization on Wednesday and now heads to the full Senate for a vote.
Tech seen as main driver to patient optimism about hospital-at-home
By
Adam Healy
Jul 11, 2024
The implied comfort, convenience and effectiveness of hospital-at-home care makes it more appealing than an inpatient stay.
Solanezumab does not slow cognitive decline in preclinical Alzheimer’s disease
Jul 19, 2023
The mean change in Preclinical Alzheimer Cognitive Composite score not significantly different at 240 weeks with solanezumab or placebo.
All participants exceeded twofold increase in spike-specific IgG, with a geometric mean fold risk of 19.5 on day 57.
Reductions seen in HbA1c, body weight with once-weekly tirzepatide
Oct 06, 2023
Estimated mean change from baseline in HbA1c was −2.1% with tirzepatide, which met noninferiority criteria and achieved superiority.
More news for Wednesday, July 3, 2024
By
Kimberly Bonvissuto
Jul 03, 2024
Sonida Senior Living acquires 9 communities, to manage 2 more … FDA approves donanemab treatment for early Alzheimer’s disease … House subcommittee advances proposal to cut HUD funding by 7% …...
Glycemic control superior with semaglutide 25 and 50 mg in Type 2 diabetes
Aug 04, 2023
Mean changes in HbA1c were significantly greater for semaglutide 25 mg or 50 mg versus 14 mg.